tretazicar has been researched along with nicotinamide-beta-riboside in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boland, MP; Davies, LC; Friedlos, F; Jarman, M; Knox, RJ | 1 |
| Abrahamson, JA; Biggs, PJ; Friedlos, F; Knox, RJ | 1 |
| Burke, PJ; Chen, S; Hobbs, SM; Jenkins, TC; Knox, RJ; Melton, RG | 1 |
3 other study(ies) available for tretazicar and nicotinamide-beta-riboside
| Article | Year |
|---|---|
Identification of novel reduced pyridinium derivatives as synthetic co-factors for the enzyme DT diaphorase (NAD(P)H dehydrogenase (quinone), EC 1.6.99.2).
Topics: Animals; Aziridines; Carcinoma 256, Walker; Coenzymes; Kinetics; NAD(P)H Dehydrogenase (Quinone); NADP; Niacinamide; Nicotinamide Mononucleotide; Oxidation-Reduction; Pyridinium Compounds; Rats; Structure-Activity Relationship; Vitamin K | 1992 |
Potentiation of CB 1954 cytotoxicity by reduced pyridine nucleotides in human tumour cells by stimulation of DT diaphorase activity.
Topics: Antineoplastic Agents; Aziridines; DNA, Neoplasm; Drug Synergism; Humans; Intracellular Fluid; Kinetics; NAD; NAD(P)H Dehydrogenase (Quinone); Niacinamide; Pyridinium Compounds; Ribonucleosides; Stimulation, Chemical; Tumor Cells, Cultured | 1992 |
Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy.
Topics: Animals; Antineoplastic Agents; Aziridines; Biotransformation; Cell Line; Cricetinae; Cricetulus; Drug Screening Assays, Antitumor; Fibroblasts; Humans; Isoenzymes; NAD(P)H Dehydrogenase (Quinone); Niacinamide; Prodrugs; Pyridinium Compounds; Substrate Specificity; Transfection; Tumor Cells, Cultured | 2000 |